New Stroke Drug Tenecteplase Poised to Revolutionize Treatment in Israel
Summarized from Ynetnews by baba
A new stroke medication, tenecteplase (TNK), is expected to become available in Israel soon, significantly shortening treatment time from an hour to seconds. This rapid injection aims to simplify emergency care and potentially improve patient recovery, offering an alternative to the current hour-long infusion of alteplase. Studies suggest TNK is as effective and safe as alteplase, with some trials indicating better functional outcomes. While TNK simplifies a key treatment stage, experts stress that rapid medical attention upon symptom onset remains critical for saving brain tissue.
The story in 5 lines · by baba
- Tenecteplase (TNK) drug to shorten stroke treatment in Israel from an hour to 10 seconds.
- TNK is as effective and safe as current alteplase, with potential for better patient recovery.
- The Israeli Stroke Society recommends TNK as preferred treatment, expected by early 2027.
- New drug simplifies a critical stage of emergency stroke care, aiding medical teams.
- Rapid medical attention upon stroke symptom recognition remains crucial for saving brain tissue.
Ynetnews publishes in English. The key points are summarized above. Read Ynetnews’s full report from the link at the top of the page.
Mentioned
